{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:28:35Z","timestamp":1774682915089,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,6]],"date-time":"2017-07-06T00:00:00Z","timestamp":1499299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["092767"],"award-info":[{"award-number":["092767"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["084633"],"award-info":[{"award-number":["084633"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.vaccine.2017.07.019","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T10:15:40Z","timestamp":1500286540000},"page":"4561-4568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"PB","title":["Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data"],"prefix":"10.1016","volume":"35","author":[{"given":"John","family":"Ojal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5808-2606","authenticated-orcid":false,"given":"Stefan","family":"Flasche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Hammitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Akech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moses C.","family":"Kiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatu","family":"Kamau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ifedayo","family":"Adetifa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Nurhonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Anthony G.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Auranen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.07.019_b0005","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/339525","article-title":"Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers","volume":"185","author":"Dagan","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.019_b0010","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00006454-199711000-00011","article-title":"Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.019_b0015","doi-asserted-by":"crossref","first-page":"e85459","DOI":"10.1371\/journal.pone.0085459","article-title":"Immunogenicity, impact on carriage and reactogenicity of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Kenyan children aged 1\u20134 years: a randomized controlled trial","volume":"9","author":"Hammitt","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.07.019_b0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.019_b0025","first-page":"8","article-title":"Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies","author":"Hammitt","year":"2014","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.vaccine.2017.07.019_b0030","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.07.019_b0035","unstructured":"Hammitt LL, Akech DO, Morpeth SC, Karani A, Nyongesa S, Ooko M, et al. Population impact of 10-valent pneumococcal conjugate vaccine (PCV) on nasopharyngeal carriage of Streptococcus pneumoniae in Kilifi, Kenya. In: 10th Int. Symp. Pneumococci Pneumococcal Dis., Glasgow, Scotland; 2016."},{"key":"10.1016\/j.vaccine.2017.07.019_b0040","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ije\/dys062","article-title":"Profile: the Kilifi Health and Demographic Surveillance System (KHDSS)","volume":"41","author":"Scott","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.07.019_b0045","doi-asserted-by":"crossref","unstructured":"Adetifa IMO, Bwanaali T, Wafula J, Mutuku A, Karia B, Makumi A, et al. Cohort profile: the Kilifi vaccine monitoring study. Int J Epidemiol 2016:dyw202. http:\/\/dx.doi.org\/10.1093\/ije\/dyw202.","DOI":"10.1093\/ije\/dyw202"},{"key":"10.1016\/j.vaccine.2017.07.019_b0050","doi-asserted-by":"crossref","first-page":"e104786","DOI":"10.1371\/journal.pone.0104786","article-title":"Quantifying age-related rates of social contact using diaries in a rural coastal population of Kenya","volume":"9","author":"Kiti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.07.019_b0055","unstructured":"Scott Anthony, Hammit Laura, Karia Boniface, Mutuku Alex, Shariff Shahnaaz, Kamau Tatu, et al. Pneumococcal conjugate vaccine impact study (PCVIS) n.d. http:\/\/kemri-wellcome.org\/programme\/pcvis-2\/ [accessed January 13, 2017]."},{"key":"10.1016\/j.vaccine.2017.07.019_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/EDE.0b013e31824f2f32","article-title":"Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition mode","volume":"23","author":"Lipsitch","year":"2012","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2017.07.019_b0065","unstructured":"R Core Team. R: a language and environment for statistical computing; 2014. https:\/\/www.r-project.org\/."},{"key":"10.1016\/j.vaccine.2017.07.019_b0070","doi-asserted-by":"crossref","unstructured":"Usuf E, Bottomley C, Adegbola RA, Hall A. Pneumococcal carriage in sub-Saharan Africa\u2013a systematic review. PLoS One 2014;9:e85001. http:\/\/dx.doi.org\/10.1371\/journal.pone.0085001.","DOI":"10.1371\/journal.pone.0085001"},{"key":"10.1016\/j.vaccine.2017.07.019_b0075","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.vaccine.2015.03.012","article-title":"Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction","volume":"33","author":"Gladstone","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.07.019_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1001839","article-title":"The potential for reducing the number of pneumococcal conjugate vaccine doses while sustaining herd immunity in high-income countries","volume":"12","author":"Flasche","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2017.07.019_b0085","unstructured":"Call for nomination for experts to serve on a Strategic Advisory Group of Experts (SAGE) on Immunization working group on Pneumococcal Conjugate Vaccine (PCV). WHO website; 2016. http:\/\/www.who.int\/immunization\/policy\/sage\/call_nominations_working_group_pcv\/en\/ [accessed December 21, 2016]."},{"key":"10.1016\/j.vaccine.2017.07.019_b0090","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1473-3099(16)00054-2","article-title":"Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study","author":"Mackenzie","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.019_b0095","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1401914","article-title":"Effects of vaccination on invasive pneumococcal disease in South Africa","volume":"371","author":"von Gottberg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.07.019_b0100","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/cid\/cis371","article-title":"Rates of acquisition of pneumococcal colonization and transmission probabilities, by serotype, among newborn infants in Kilifi district, Kenya","volume":"55","author":"Tigoi","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.019_b0105","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.1215947","article-title":"Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes","volume":"335","author":"Cobey","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.07.019_b0110","doi-asserted-by":"crossref","first-page":"20131939","DOI":"10.1098\/rspb.2013.1939","article-title":"The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination","volume":"280","author":"Flasche","year":"2013","journal-title":"Proc Biol Sci"},{"key":"10.1016\/j.vaccine.2017.07.019_b0115","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2013.0786","article-title":"A mathematical model of serotype replacement in pneumococcal carriage following vaccination","volume":"10","author":"Bottomley","year":"2013","journal-title":"J R Soc Interf"},{"key":"10.1016\/j.vaccine.2017.07.019_b0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2471\/BLT.10.080796","article-title":"Sensitivity of hospital-based surveillance for severe disease: a geographic information system analysis of access to care in Kilifi district, Kenya","volume":"89","author":"Mo\u00efsi","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2017.07.019_b0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"O\u2019Brien","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.07.019_b0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.07.019_b0135","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.07.019_b0140","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000242576","article-title":"Colonisation of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage, and relationship to carriage in mothers","volume":"50","author":"Gratten","year":"1986","journal-title":"Biol Neonate"},{"key":"10.1016\/j.vaccine.2017.07.019_b0145","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/528688","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study","volume":"46","author":"Hill","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.07.019_b0150","doi-asserted-by":"crossref","unstructured":"Montgomery J, Lehmann D, Smith T, Michael A, Joseph B, Lupiwa T, et al. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in Highland children of Papua New Guinea. Rev Infect Dis 1990;Suppl. 8:S1006-16.","DOI":"10.1093\/clinids\/12.Supplement_8.S1006"},{"key":"10.1016\/j.vaccine.2017.07.019_b0155","doi-asserted-by":"crossref","unstructured":"Lebon A, Verkaik NJ, Labout JAM, de Vogel CP, Hooijkaas H, Verbrugh HA, et al. Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study. Infect Immun 2011;79:1680\u20137. http:\/\/dx.doi.org\/10.1128\/IAI.01379-10.","DOI":"10.1128\/IAI.01379-10"},{"key":"10.1016\/j.vaccine.2017.07.019_b0160","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/CVI.00247-09","article-title":"Maternal antibodies to pneumolysin but not to pneumococcal surface protein a delay early pneumococcal carriage in high-risk Papua New Guinean infants","volume":"16","author":"Francis","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.07.019_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children - a population-based study","volume":"10","author":"Jokinen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.07.019_b0170","doi-asserted-by":"crossref","unstructured":"Lucero MG, Dulalia VE, Nillos LT, Williams G, Parre\u00f1o RAN, Nohynek H, et al. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age. Cochrane Database Sytematic Rev 2009 2010;CD004977 [Review].","DOI":"10.1002\/14651858.CD004977.pub2"},{"key":"10.1016\/j.vaccine.2017.07.019_b0175","doi-asserted-by":"crossref","unstructured":"Choi YH, Jit M, Gay N, Andrews N, Waight PA, Melegaro A, et al. 7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement? PLoS One 2011;6:e26190. http:\/\/dx.doi.org\/10.1371\/journal.pone.0026190.","DOI":"10.1371\/journal.pone.0026190"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17309155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17309155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T11:20:54Z","timestamp":1569842454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17309155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":35,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0264410X17309155"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}